These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 17676389)

  • 1. Emerging role of combination of all-trans retinoic acid and interferon-gamma as chemoimmunotherapy in the management of human glioblastoma.
    Haque A; Banik NL; Ray SK
    Neurochem Res; 2007 Dec; 32(12):2203-9. PubMed ID: 17676389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of apoptosis and immune response by all-trans retinoic acid plus interferon-gamma in human malignant glioblastoma T98G and U87MG cells.
    Haque A; Das A; Hajiaghamohseni LM; Younger A; Banik NL; Ray SK
    Cancer Immunol Immunother; 2007 May; 56(5):615-25. PubMed ID: 16947022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of all-trans retinoic acid and interferon-gamma suppressed PI3K/Akt survival pathway in glioblastoma T98G cells whereas NF-kappaB survival signaling in glioblastoma U87MG cells for induction of apoptosis.
    Zhang R; Banik NL; Ray SK
    Neurochem Res; 2007 Dec; 32(12):2194-202. PubMed ID: 17616812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of all-trans retinoic acid and interferon-gamma upregulated p27(kip1) and down regulated CDK2 to cause cell cycle arrest leading to differentiation and apoptosis in human glioblastoma LN18 (PTEN-proficient) and U87MG (PTEN-deficient) cells.
    Zhang R; Banik NL; Ray SK
    Cancer Chemother Pharmacol; 2008 Aug; 62(3):407-16. PubMed ID: 17960384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation decreased telomerase activity in rat glioblastoma C6 cells and increased sensitivity to IFN-gamma and taxol for apoptosis.
    Das A; Banik NL; Ray SK
    Neurochem Res; 2007 Dec; 32(12):2167-83. PubMed ID: 17694433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining cytotoxic and immune-mediated gene therapy to treat brain tumors.
    Curtin JF; King GD; Candolfi M; Greeno RB; Kroeger KM; Lowenstein PR; Castro MG
    Curr Top Med Chem; 2005; 5(12):1151-70. PubMed ID: 16248789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in Immunotherapy for Glioblastoma Multiforme.
    Huang B; Zhang H; Gu L; Ye B; Jian Z; Stary C; Xiong X
    J Immunol Res; 2017; 2017():3597613. PubMed ID: 28299344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of all-trans retinoic acid and paclitaxel-induced differentiation and apoptosis in human glioblastoma U87MG xenografts in nude mice.
    Karmakar S; Banik NL; Ray SK
    Cancer; 2008 Feb; 112(3):596-607. PubMed ID: 18098270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Not Available].
    Baldini C; Romano PM; Varga A; Champiat S; Dumont S; Dhermain F; Louvel G; Marabelle A; Postel-Vinay S; Angevin E; Gazzah A; Ribrag V; Bahleda R; Michot JM; Hollebecque A; Soria JC; Massard C
    Bull Cancer; 2018 Dec; 105 Suppl 1():S59-S67. PubMed ID: 30595200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [What's next in glioblastoma treatment: Tumor-targeted or immune-targeted therapies?].
    Schernberg A; Marabelle A; Massard C; Armand JP; Dumont S; Deutsch E; Dhermain F
    Bull Cancer; 2016 May; 103(5):484-98. PubMed ID: 27032303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of all-trans retinoic acid and taxol regressed glioblastoma T98G xenografts in nude mice.
    Karmakar S; Banik NL; Patel SJ; Ray SK
    Apoptosis; 2007 Nov; 12(11):2077-87. PubMed ID: 17701358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of retinoic acid and interferon alpha-2a on transitional cell carcinoma of bladder.
    Zou C; Ramakumar S; Qian L; Zou C; Zang R; Wang J; Grossman HB; Lotan R; Liebert M
    J Urol; 2005 Jan; 173(1):247-51. PubMed ID: 15592090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amino acid PET tracers are reliable markers of treatment responses to single-agent or combination therapies including temozolomide, interferon-β, and/or bevacizumab for glioblastoma.
    Ono T; Sasajima T; Doi Y; Oka S; Ono M; Kanagawa M; Baden A; Mizoi K; Shimizu H
    Nucl Med Biol; 2015 Jul; 42(7):598-607. PubMed ID: 25892210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gamma interferon-mediated superinduction of B7-H1 in PTEN-deficient glioblastoma: a paradoxical mechanism of immune evasion.
    Han SJ; Ahn BJ; Waldron JS; Yang I; Fang S; Crane CA; Pieper RO; Parsa AT
    Neuroreport; 2009 Dec; 20(18):1597-602. PubMed ID: 19875977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in therapy for glioblastoma.
    Clarke J; Butowski N; Chang S
    Arch Neurol; 2010 Mar; 67(3):279-83. PubMed ID: 20212224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunotherapy targeting the Wilms' tumor 1 gene product for patients with malignant brain tumors].
    Hashimoto N; Tsuboi A; Chiba Y; Izumoto S; Oka Y; Yoshimine T; Sugiyama H
    Brain Nerve; 2009 Jul; 61(7):805-14. PubMed ID: 19618858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined stimulation with interferon alpha and retinoic acid synergistically inhibits proliferation of the glioblastoma cell line GB12.
    Ohno S; Nishi T; Kojima Y; Haraoka J; Ito H; Mizuguchi J
    Neurol Res; 2002 Oct; 24(7):697-704. PubMed ID: 12392208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine-based immunotherapy for glioblastoma.
    Thomas AA; Fisher JL; Ernstoff MS; Fadul CE
    CNS Oncol; 2013 Jul; 2(4):331-49. PubMed ID: 25054578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced efficacy of the combination of all-trans-retinoic acid and gamma-interferon in inhibiting proliferation of Tca8113 cells.
    Chen W; He R; Zhang Z; Lin G; Zhou X
    Chin J Dent Res; 1999 Feb; 2(1):54-60. PubMed ID: 10557185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Innovative Immunotherapy Vaccine with Combination Checkpoint Blockade as a First Line Treatment for Glioblastoma in the Context of Current Treatments.
    Coxon AT; Johanns TM; Dunn GP
    Mo Med; 2020; 117(1):45-49. PubMed ID: 32158049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.